Form 8-K - Current report:
SEC Accession No. 0001437749-25-023293
Filing Date
2025-07-23
Accepted
2025-07-23 09:31:36
Documents
14
Period of Report
2025-07-23
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K blgo20250723_8k.htm   iXBRL 8-K 29564
2 EXHIBIT 99.1 - PRESS RELEASE ex_842318.htm EX-99.1 51416
  Complete submission text file 0001437749-25-023293.txt   223068

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blgo-20250723.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blgo-20250723_def.xml EX-101.DEF 11056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blgo-20250723_lab.xml EX-101.LAB 14798
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blgo-20250723_pre.xml EX-101.PRE 11161
16 EXTRACTED XBRL INSTANCE DOCUMENT blgo20250723_8k_htm.xml XML 2731
Mailing Address 14921 CHESTNUT ST. WESTMINSTER CA 92683
Business Address 14921 CHESTNUT ST. WESTMINSTER CA 92683 888 400-2863
BIOLARGO, INC. (Filer) CIK: 0000880242 (see all company filings)

EIN.: 650159115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19709 | Film No.: 251141857
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)